Dougherty's Pharmacy, Inc. (MYDP) [Rocket]

Overview

Dougherty's Pharmacy, Inc. (MYDP)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
03/16/2021	REVOKED	Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
12/18/2020	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
08/30/2019	8-K	Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, O...
07/12/2019	8-K	Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vo...
05/23/2019	10-Q/A	Quarterly Report for the period ended March 31, 2019 [amend]
05/20/2019	10-Q	Quarterly Report for the period ended March 31, 2019
05/15/2019	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-06	Dec-31-05	Dec-31-04	Dec-31-03	Jun-30-03
Revenues	36.1	40.2	42.8	55.4	53.0	39.3	0.5	39.4
Revenue growth	-10.3%	-6.0%		4.6%	34.8%	7680.4%		-10.1%
Cost of goods sold	26.9	29.4	31.7	36.5	34.7	25.1	0.0	25.4
Gross profit	9.1	10.8	11.1	19.0	18.2	14.2	0.5	14.0
Gross margin	25.3%	26.9%	25.8%	34.2%	34.4%	36.2%	100.0%	35.6%
Selling, general and administrative	9.3	10.4	10.4	16.2	16.9	13.1	1.5	5.7
EBIT	-1.1	-0.6	-0.5	2.4	1.3	1.0	-1.0	0.7
EBIT margin	-2.9%	-1.4%	-1.1%	4.3%	2.4%	2.5%	-204.4%	1.8%
Pre-tax income	-1.5	-1.1	-4.8	1.1	0.6	0.5	-1.1	-1.0
Income taxes	2.0	1.0	0.0	0.2	0.2	0.2	0.0	0.0
Tax rate				19.3%	41.1%	35.2%	0.0%	0.0%
Earnings from continuing ops	-3.5	-2.1	-4.9	0.8	0.3	0.2	-0.8	-1.0
Earnings from discontinued ops				1.0	0.1	0.2	-0.8	-0.8
Net income	-3.5	-2.1	-4.9	1.8	0.4	0.5	-1.6	-1.7
Net margin	-9.8%	-5.2%	-11.4%	3.3%	0.7%	1.3%	-324.0%	-4.4%

Diluted EPS	($0.15)	($0.09)	($0.22)	$0.03	$0.01	$0.01	($0.04)	($0.03)
Shares outstanding (diluted)	23.1	22.5	22.2	22.7	22.9	22.4	21.6	36.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.